-FBN
Related Posts
Guggenheim Reiterates Buy on Summit Therapeutics, Maintains $40 Price Target
Guggenheim analyst Brad Canino reiterates Summit Therapeutics (NASDAQ:SMMT) with a Buy and maintains $40 price target.
12 Consumer Discretionary Stocks Moving In Monday’s After-Market Session
Gainers
GrowGeneration (NASDAQ:GRWG) stock increased by 6.8% to $3.79 during Monday's after-market session. The company's market cap stands at $230.4 million.
Telsey Advisory Group Maintains Outperform on Rent the Runway, Lowers Price Target to $13
Telsey Advisory Group analyst Dana Telsey maintains Rent the Runway (NASDAQ:RENT) with a Outperform and lowers the price target from $21 to $13.